Healthcare M&A Post-Pandemic — Opportunities, Not Opportunism
The healthcare industry has been devastated by the COVID-19 pandemic, and post-pandemic deals, partnerships, and mergers are expected to rise. King & Spalding attorneys and a senior vice president at ReviveHealth say as health systems race to the altar to beat out competitors for M&A targets and other strategic relationships, it’s critical that they are thoughtful in structuring their deals, justifying the activity, and communicating the benefits.
The COVID-19 pandemic has devastated the healthcare industry. In addition to the tragedies that the pandemic has brought, health systems have universally experienced severe and rapid deterioration of their bottom lines due to plummeting patient volumes, pausing of high margin elective surgical procedures, and increased expenses.
By some estimates, health system losses will be around $200 billion by the end of June and revenues have dropped by around 50 percent. As a result of the financial uncertainty caused by the pandemic, many hospitals and health systems terminated or delayed potential transactions as they focused on managing the crisis and protecting their workforces and communities.
But this may just be the calm before a big M&A storm.
Rise in M&A Activity
Through our work as legal and communications counselors, we have seen preliminary M&A activity rise in recent weeks, with providers exploring and negotiating transactions, including several that have not yet been publicly announced.
Some systems are looking to capitalize on the time between the end of the first wave of COVID-19 and a potential resurgence in the fall to get letters of intent finalized and announced. This coming M&A activity presents legal and communications challenges when the national spotlight is firmly on health systems.
Providers are starting to resurrect deals that were paused during the initial period of the COVID-19 crisis, including Community Health System’s sale of Abilene Regional Medical Center and Brownwood Regional Medical Center to Hendrick Health System.
Some systems are seeking new strategic partners, such as Lake Health in Ohio, and New Hanover Regional Medical Center in North Carolina, which resumed its recent RFP response process after a pause.
Still others are looking for new opportunities consistent with pre-COVID-19 growth strategies, as adjusted for pandemic-related developments and challenges.
Larger and more financially robust health systems are expected to weather the crisis, whereas smaller systems and hospitals with less cash and tighter operating margins, including rural and critical access hospitals, may be facing insolvency, closure, and bankruptcy. This creates a scenario where one party is financially distressed as a result of the pandemic and needs to partner with or join another system to survive. These circumstances will likely fuel increased consolidation in the healthcare industry.
For a struggling provider, joining a larger system can offer much-needed financial commitments, access to capital, disciplined management structure, economies of scale for purchasing, and improved IT infrastructure, among many other strategic benefits. A well-positioned system, even if financially weakened due to pandemic challenges, will be able to negotiate favorable deal terms if it has significant strategic value to its prospective partner.
Communications Strategy is Important
As providers explore and execute partnerships, they must implement a stakeholder and communications strategy that focuses on benefits for each side given the new financial reality. Doing so will minimize criticism of opportunism by the acquiring system—and best position a definitive agreement and successful deal.
An effective communications strategy will emphasize how the proposed transaction will maintain or improve quality or affordability, ensure access to care for communities, and address financial challenges faced by health systems as a result of the pandemic.
Health systems should articulate how their M&A activity will stabilize affected health systems, allow them to manage the COVID-19 crisis and future pandemics, and continue to meet the overall care needs of the community. It can also highlight how these partnerships will facilitate continued care in a market, which otherwise might lose a valuable healthcare resource, as well as the positive economic benefits the transaction will bring for local communities.
Communications that support the vision, rationale and benefits of a deal will also need to be relevant to the regulatory bodies whose approval may be required.
Public perception and support of healthcare providers have been extremely positive during the pandemic to date, as evidenced by homemade banners, balcony tributes, and praise on social media. Health systems and their staffs have borne personal risk and financial pain by focusing on patients and public health at the expense of all else. This goodwill can be valuable as health systems seek stakeholder and community support for their transactions.
That goodwill can also quickly be forgotten.
As health systems race to the altar to beat out competitors for M&A targets and other strategic relationships, it is critical that they are thoughtful in structuring their deals and justifying the activity.
For example, acquisitions and partnerships involving substantial outlays of capital and lucrative executive compensation or severance packages will be viewed negatively if undertaken by a system that instituted large compensation reductions across the system or even furloughed or laid off employees during the pandemic.
As the dust begins to settle from the first wave of COVID-19, it is clear that there will be drastic changes to how health systems do business. The pandemic will also create financial winners and losers. Hospitals and health systems must think proactively about a strategy for growth as opportunities with willing transaction partners arise.
But being proactive must be balanced against appearing to be opportunistic or taking advantage of the worst health crisis in our lifetimes. To maintain their goodwill and reputations, health systems should continue to do deals for the right reasons and for the benefit of their communities.
*As seen in Bloomberg Law. This column does not necessarily reflect the opinion of The Bureau of National Affairs, Inc. or its owners.
Torrey McClary is a partner at King & Spalding in the Los Angeles office, where her practice focuses on healthcare M&A, restructurings and other complex transactions.
Ranee Adipat is a counsel at King & Spalding and is based in Denver. She focuses primarily on mergers and acquisitions in the healthcare industry.
Ryan Colaianni is a senior vice president and issues/crisis practice lead at ReviveHealth, a healthcare focused communications and marketing agency.